Liquid-based cytology (LBC) is a useful cytopathological method, and LBC lung adenocarcinoma specimens may be used for genetic analysis in the near future. In the current study, the authors determined whether LBC specimens can be used for epidermal growth factor receptor (EGFR) mutation analysis in human lung adenocarcinoma cell lines. METHODS: Genomic DNA was extracted from 3 lung adenocarcinoma cell lines that were fixed in LBC preservation solution using 2 protocols (one for cultured cells and one for tissues) of a DNA extraction kit. Different fixation times were tested for each protocol: 30 minutes, 1 hour, and 1 to 9 days. As controls, cells also were fixed in 10% formalin or 95% ethanol. The authors investigated the effect of fixation time on DNA fragmentation, polymerase chain reaction (PCR) amplification, and EGFR mutation detection. RESULTS: The DNA yield of LBC specimens tended to decrease depending on fixation time. When using the DNA extraction protocol for tissues, PCR amplification was successful after 9 days of fixation, although extracted genomic DNA that was fixed for >1 hour demonstrated fragmentation. Mutation analyses using the Cycleave PCR method were successful after 7 days of fixation. The DNA extraction protocol for tissues was appropriate for lung adenocarcinoma cell lines that were stored for >1 day in a preservative solution. The results of the current study demonstrated that EGFR mutations can be detected on day 7 using lung adenocarcinoma cell lines fixed in CytoRich Red preservative. CONCLUSIONS: When LBC specimens are used for targeted molecular genetic testing, the appropriate preservative solution and extraction protocol first should be determined.
INTRODUCTION
Cytology plays an important role in the diagnosis of lung cancers, especially if the tumor is situated within the periphery of the lung fields. Recently, liquid-based cytology (LBC) has become a useful cytopathological method for diagnosis. In the early 2000s, the LBC method began to be used widely, especially in gynecological malignancies. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] LBC has advantages in that uniform specimens can be prepared, drying is avoided, and there is less sample loss. Consequently, fewer unsatisfactory specimens are produced. [5] [6] [7] [8] [9] [10] Therefore, the use of LBC specimens for the clinical diagnosis of respiratory malignancies also is expected. 12 Lung cancer has many histological types, and a histological diagnosis of the disease is very important for informing therapeutic strategies. In patients with lung adenocarcinoma in particular, targeted tyrosine kinase inhibitor therapy provides significant improvements in survival and quality of life. In addition, molecular
Cancer Cytopathology December 2018 testing for epidermal growth factor receptor (EGFR) or other genes can predict the patient's response to treatment. Mutation testing for the selection of patients with lung cancer who will receive tyrosine kinase inhibitor therapy is recommended by the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology. [13] [14] [15] [16] Clinically, a cytological specimen is useful material that can be applied for molecular testing, such as the determination of EGFR mutation status. A key parameter for successful analysis is the quality and quantity of the extracted DNA. The fragmentation of DNA extracted from formalin-fixed paraffin-embedded (FFPE) specimens is well known. The degree of damage to FFPE specimens is affected not only by the formalin fixation time before being embedded in paraffin but also the storage time of the paraffin block. Moreover, formalin treatment is known to cause protein-nucleic acid, nucleic acid-nucleic acid, and protein-protein crosslinks, which affect the amount of DNA that can be extracted and induce sequence artifacts. [17] [18] [19] Some commercial preservative solutions for LBC include formaldehyde to improve the imaging of specimens; however, the percentage of formaldehyde in LBC preservation solutions usually is lower than that in common fixative solutions such as buffered formalin for FFPE specimens. Recently, Fujii et al 20 reported that genomic DNA extracted from human urothelial carcinoma and cervical cancer cell lines that were fixed in several commercial LBC solutions could be used in genetic analyses, although DNA expression decreased with longer fixation times. Molecular testing for EGFR mutations has been performed successfully on clinical cytological lung cancer materials. DNA extraction from LBC specimens has been performed for single-gene assays [21] [22] [23] and multiplex platforms including next-generation sequencing. 24 In the current study, we determined whether the LBC preservative solution used to fix samples affected the nucleic acids of the extracted DNA and whether the extracted DNA could be used to detect EGFR mutations in human lung adenocarcinoma cell lines. To the best of our knowledge, the current study is the first in vitro study involving short-term storage using LBC specimens of lung adenocarcinoma cell lines. This study will be helpful for clinical diagnosis using cytology.
MATERIALS AND METHODS

Ethics Statement
The current study was performed according to the Declaration of Helsinki and was approved by the ethics committee of Kitasato University Medical Ethics Organization (approval KME B14-155).
Cell Lines
Three human lung adenocarcinoma cell lines-A549, PC-9, and H1975-were used in the current study. A549 cells were purchased from the Japanese Collection of Research Bioresources (Kanagawa, Japan), PC-9 cells were purchased from the 
Genomic DNA Extraction
Genomic DNA from fixed cells was purified using a silica column-based QIAamp DNA Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions but with some modifications of the reaction time (Fig. 1) .
To determine the optimal purification protocol for LBC specimens, we compared the following 2 protocols: one for cultured cells (FC) and one for tissues (FT). Fixed cells were centrifuged at 2000 to 7000 × g for 5 minutes at room temperature and washed once with PBS. Protocol FC was performed as follows. The washed cell pellet was resuspended in 200 µL of PBS, and the following were added in order: 20 µL of proteinase K and 200 µL of lysis buffer (buffer AL). After pulse vortexing for 15 seconds, cells were incubated for 30 minutes (the original protocol states 10 minutes) at 56°C. Protocol FT was performed as follows. The step for tissue dissection was omitted. The washed cell pellet was resuspended in 80 µL of PBS and the following were added in order: 100 µL of tissue lysis buffer (buffer ATL) and 20 µL of proteinase K. After vortexing, cells were incubated for 30 minutes (the original protocol states 1-3 hours, overnight, or until dissolved) at 56°C. After incubation, 200 µL of buffer AL was added, followed by incubation at 70°C for 10 minutes.
In both protocols, the following washing procedures were performed according to the manufacturer's instructions. The volume of the final genomic DNA solution was 200 µL, and it was eluted twice with 100 µL of buffer AE after incubation for 10 minutes at room temperature (the original protocol states 1 minute). To 
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obtain RNase-free genomic DNA, genomic DNA was treated with RNase A (Qiagen) according to the manufacturer's instructions. Extracted DNA was quantified using a NanoDrop ND-1000 UV-Vis Spectrophotometer (Thermo Fisher Scientific) and stored at 4°C.
DNA Fragmentation Analysis and PCR Amplification
To analyze DNA fragmentation, genomic DNA samples (500 ng/lane) were loaded into a 0.8% agarose gel in 0.5× tris-borate-EDTA buffer and separated by gel electrophoresis. Next, to evaluate the efficiency of PCR, primers for the EGFR gene were used, and samples of genomic DNA (100 ng) were amplified using AmpliTaq Gold 360 PCR Master Mix (Thermo Fisher Scientific). EGFR exon 19 (190 base pair [bp]) was analyzed using A549 and PC-9 samples, and EGFR exon 21 (190 bp) was analyzed using H1975 samples (3-5 samples). The cycling conditions were as follows: initial denaturation at 95°C for 10 minutes followed by 35 cycles of 95°C for 30 seconds, 60°C for 30 seconds, and 72°C for 30 seconds, and then a final extension at 72°C for 7 minutes using a T100 Thermal cycler (Bio-Rad, Hercules, California). A total of 3 µL of the PCR product out of the 20-µL total reaction volume was loaded in each lane of a 1.5% agarose gel in 0.5× tris-borate-EDTA buffer and separated by gel electrophoresis. The agarose gels were stained with ethidium bromide solution, and the amplified DNA bands were semiquantified.
EGFR Mutation Analysis
To determine whether genomic DNA extracted from H1975 cells fixed in CytoRich Red was suitable for the detection of EGFR mutations, DNA products extracted using protocol FT were analyzed. We performed Cycleave PCR to compare the fixation methods using 10% formalin and 95% ethanol. Exon 20 (T790M) and exon 21 (L858R) of EGFR were analyzed by Cycleave PCR using the Real-Time PCR System (StepOnePlus; Thermo Fisher Scientific). Samples of genomic DNA (5 ng) were amplified using Cycleave PCR Reaction Mix (Takara Bio, Shiga, Japan). DNA damage and fragmentation were evaluated by comparing the threshold cycle (Ct) values for each fixation time on days 1, 3, 5, and 7. Analyses were performed in triplicate. The cycling conditions were as follows: initial denaturation at 95°C for 10 minutes followed by 45 cycles of 95°C for 5 seconds, 52°C for 7 seconds, and 72°C for 10 seconds, and a final extension at 72°C for 10 seconds.
Statistical Analysis
The Wilcoxon Kruskal-Wallis comparison test was used. P values <.05 were considered to be statistically significant. Data were expressed as the mean ± the standard error of the mean. Statistical analysis was performed with JMPPro 13.2 software (SAS Institute Inc, Cary, North Carolina).
RESULTS
Genomic DNA Yield and Quality
For all 3 cell lines fixed in CytoRich Red, the yield of nucleic acid extracted using both protocols gradually decreased as the fixation time increased. When protocol FT was used, the decrease in genomic DNA was gradual and stabilized after 1 hour to 1 day of fixation, whereas the decrease with protocol FC was dependent on the fixation time ( Figs. 2A-2C ). For the yields of nucleic acid from samples fixed in 10% formalin, genomic DNA decreased suddenly after 1 day of fixation (Fig. 2D) , whereas for samples fixed in 95% ethanol, genomic DNA was stable from 30 minutes to 9 days of fixation for both extraction protocols (Fig. 2E) . The average DNA purity (ratio of the absorbance at 260-280 nm) for all samples was 2.1 for both protocols.
Visualization of genomic DNA by agarose gel electrophoresis is shown in Figure 3 . For the protocol FC group, the same fragment pattern was observed for unfixed samples and those fixed for 30 minutes and 1 hour for all cell lines fixed in CytoRich Red. The 23-kilobase pair (kb) fragment disappeared after 1 day of fixation in the majority of samples, and smears were observed below 1.5-kb pairs (Figs. 3A, 3C, and 3E ). For the protocol FT group, the same fragment pattern observed in protocol FC was observed for unfixed samples and those fixed for 30 minutes and 1 hour. However, the 23-kb pair fragment was observed weakly from days 1 to 2, which was different from that observed for the protocol FC group (Figs. 3B, 3D, and 3F ). In the 10% formalin group, DNA or RNA smears were observed for all fixation times using protocol FC (Fig. 3G) . The 23-kb pair fragment was observed only for the fixation times of 30 minutes and 1 hour, and smears were observed except for the 30-minute and 1-hour fixation times using protocol FT (Fig. 3H) . In the 95% ethanol group, undegraded genomic DNA was observed clearly for the 23-kb pair fragment for a fixation time of 30 minutes through 9 days for both extraction protocols (Figs. 3I and 3J ). When the genomic DNA of A549 cells was treated with RNase, the bands at 0.2-kb to 3-kb pairs disappeared. The distinct band at 23-kb pairs was undegraded DNA, and the smeared Cancer Cytopathology December 2018 band at 4-kb to 10-kb pairs represented the degraded DNA (Fig. 4) .
PCR Analyses of the EGFR Gene
The amplification of the EGFR gene using the genomic DNA extracted from each cell line fixed in CytoRich Red was assessed for the different fixation times. In the protocol FC group, high levels of the amplified PCR products were detected at the fixation times of 30 minutes and 1 hour, and they were recognized as unfixed specimens, but the detection was poor or amplification was not observed after day 1. In the protocol FT group, Figure 3 . Representative images of DNA fragmentation throughout the fixation time. (A-F) Genomic DNA extracted using the protocols for cultured cells and for tissues from A549, PC-9, and H1975 cells fixed in CytoRich Red preservative. (G-J) Genomic DNA extracted using the protocols for cultured cells and for tissues from H1975 cells fixed in 10% formalin and 95% ethanol. A total of 500 ng of DNA was electrophoresed in 0.8% agarose gels. Lanes M1 and M2 show the 100-base pair (bp) DNA ladder marker and λ-Hind III digest marker, respectively. high levels of amplified PCR products were detected as unfixed specimens at 30 minutes through day 2, and clear amplification was observed at days 3 and 4; the PCR products were slightly decreased after day 4. A similar tendency was observed for all cell lines (Fig. 5A ). In the 10% formalin group, PCR amplification efficiencies were very low at all fixation times, although weak bands were observed at 30 minutes, which was the shortest fixation time in the protocol FC group. In contrast to those in the protocol FT group, PCR amplification in the 10% formalin group was poor at all fixation times. In the 95% ethanol group, PCR amplifications were successful at all fixation times for both extraction protocols (Fig. 5B) .
Assessment of DNA Fragmentation With Ct Value Using Cycleave PCR
To assess the fragmentation of genomic DNA in addition to its visualization, we compared Ct values of quantitative PCR by the Cycleave PCR method. The mutation of EGFR exon 20 (T790M) and exon 21 (L858R) in H1975 cells was observed for all fixative times (days 1, 3, 5, and 7) and in all fixation methods. Analyses of T790M and L858R revealed almost the same trends. The samples fixed in 10% formalin and CytoRich Red exhibited increased Ct values along the fixation time, whereas the samples fixed in 95% ethanol had consistently low Ct values. After fixation for 1 day, Ct values were significantly lower for samples fixed in CytoRich Red than for samples fixed in 10% formalin in both T790M and L858R analyses (CytoRich Red vs 10% formalin: 34.6 vs 37.9 and 29.9 vs 33.8, respectively; P<.0495) (Fig. 6 ). In addition, on day 7, the Ct values of the samples fixed in CytoRich Red were significantly lower than those of samples fixed in 10% formalin in T790M analysis, although the Ct values of samples fixed in CytoRich Red were significantly higher than those of samples fixed in 10% formalin on day 5 in L858R analysis.
DISCUSSION
The results of the current study indicate that genomic DNA extracted from human adenocarcinoma cell lines fixed in CytoRich Red can be used for EGFR mutation detection. It is necessary to first determine the characteristics of the LBC preservation solution and the conditions under which it can be used to perform the required genetic analyses. Moreover, before using LBC specimens for the first time for new molecular tests, cell lines should be used to verify whether the DNA extraction protocol is suitable for the target specimens and whether the DNA products can be used for molecular testing. Thereafter, the protocol should be assessed using clinical specimens.
With regard to the extraction protocol, samples extracted using protocol FT tended to have more undegraded DNA compared with those extracted using protocol FC, and EGFR could be amplified successfully by PCR with extraction times up to 9 days. Agreda et al 25 analyzed genomic DNA extracted from LBC specimens fixed in a preservation solution containing a lower concentration of formaldehyde than that in CytoRich Red and successfully amplified the DNA by PCR using a commercial extraction kit for tissues. In the current study, protocol FT was determined to be the optimal method for LBC specimens containing formaldehyde. The major differences in the procedures between protocols FC and FT were lysis with proteinase K in buffer ATL at 56°C and dissolution with buffer AL at 70°C after proteinase K treatment in protocol FT. Generally, proteinase K digestion and heat treatment remove DNA crosslinks, which affect the quality and quantity of DNA. We also examined the effect of proteinase K treatment time on nucleic acid yield using PC-9 cells fixed in CytoRich Red. Various treatment times were compared (10 minutes, 30 minutes, 1 hour, 4 hours, and overnight) using protocol FT, and nucleic acid yield and 
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fragmentation by agarose gel electrophoresis were nearly the same for all tested times (data not shown). The manufacturer's instructions stated that incubation times >10 minutes would have no effect on the quality of purified DNA when using protocol FC. Thus, a 30-minute lysis treatment with proteinase K was performed for both protocols in the current study. To our knowledge, the current study is the first report to compare the protocols FC and FT in the same specimens.
The results of the analysis performed with DNA extracted from H1975 cells fixed in 95% ethanol indicated that genomic DNA was undegraded and stable from 30 minutes to 9 days of fixation. Therefore, DNA degradation in the other fixation groups likely was caused by crosslinking induced by formaldehyde. When using the QIAamp DNA Mini Kit (Qiagen), DNA extracted from cells fixed in preservation solutions that contain formaldehyde should be dissolved thoroughly using the 2 buffers, ATL and AL, because it appears that treatment with buffer AL alone does not sufficiently remove crosslinks. Crosslinking most likely is strong after 1 hour to 1 day of fixation with CytoRich Red because the 23-kb genomic DNA fragment and PCR band were positive at 1 hour when protocol FC was used. For DNA extracted from specimens fixed for 1 hour to 2 days using protocol FC, specimens demonstrated reduced yields. Fixation with 10% formalin resulted in a marked increase in crosslinking according to the results of gel electrophoresis and PCR. In addition, we propose that treatment with proteinase K and heating at 56°C are sufficient for crosslink removal in specimens fixed in CytoRich Red because the formaldehyde concentration is lower and fixation time is shorter than those in FFPE specimens. The results of the current study indicated that the extraction method is very important when LBC specimens fixed in a preservation solution containing formaldehyde are used for genetic analysis, and not only the fixation time but also the extraction method should be considered.
With regard to DNA quality, fixation in 95% ethanol has been reported in previous studies to result in better stability than fixation in CytoRich Red or 10% formalin. 26, 27 Ethanol fixatives have powerful effects on the stability of nucleic acids, and thus improved results may be observed by using ethanol. For example, when preparing a specimen, a sample for DNA extraction could be placed in 95% ethanol after a 30-minute incubation in CytoRich Red. Alternatively, DNA could be extracted from duplicate LBC slides that are stored in 95% ethanol if adequate storage space is available. Kawahara et al 28 reported that DNA extracted from human lung cancer cell lines fixed in CytoRich Red was more suitable for immunocytochemistry using EGFR mutation-specific antibodies than that extracted from cell lines fixed in ethanol or formalin. They also reported that DNA extracted from LBC specimens preserved for 5 days or 40 days at room temperature can be used to detect EGFR mutations, but details were not included. The results of the current study demonstrated that the DNA fragmentation caused by storage for up to approximately 5 days did not adversely affect molecular testing when fixed specimens were used with CytoRich Red or 10% formalin. In addition, CytoRich Red inhibits the progression of fragmentation over fixation time >10% formalin. A previous study reported that degraded DNA extracted from LBC specimens could be positively amplified to produce an approximately 250-bp DNA segment. 2 We also successfully performed PCR amplifications and Cycleave PCR analyses of EGFR despite DNA degradation. To determine the optimal preservation time, the fragmentation level was evaluated by Ct values based on Cycleave analysis to detect EGFR mutations. Although CytoRich Red originally was designed for cytodiagnosis, it also can be used for molecular genetic diagnoses such as EGFR mutation detection. Because the amplicon size of EGFR was approximately 200 bp in the current study, genomic DNA extracted from specimens fixed in CytoRich Red contained adequate fragment lengths typically used for molecular analysis. In the near future, DNA extracted from LBC specimens may be used to amplify longer fragments, such as for mate-pair sequencing (2-5 kb) or long-range PCR (20-30 kb) . Such amplifications would be difficult using present FFPE methods because 30% to 40% of degraded DNA samples extracted from FFPE specimens failed to amplify a fragment of 1182 bp. 29 Moreover, FFPE specimens fixed in 10% buffered neutral formalin for >72 hours failed to amplify a fragment of 1327 bp. 26 Dejmek et al 30 specimens should be considered, and we plan to investigate this further in the future. In terms of clinical use, Papanicolaou staining requires the verification of a sufficient number of tumor cells in LBC specimens, and the uniformity of LBC is helpful in this regard. Genomic DNA extraction requires sufficient target cell numbers. Fujii et al 20 reported that genomic DNA derived from a small number of LBC specimens could be used for molecular testing. Thus, the minimum percentage of tumor cells required in LBC specimens to extract a sufficient quantity of DNA for molecular testing should be verified by microscopy. To obtain the necessary data, LBC specimens prepared from mixed cell lines containing some wild-type and some tumor cells should be examined to determine whether the percentage of tumor cells correlates with the sensitivity of mutation detection. Moreover, examination using clinical specimens will be necessary. In addition, cytological specimens should be free of impurities such as blood or other components. Within this context, LBC preservation solution, which exhibits hemolytic properties and protein solubilization activity due to the low formaldehyde content, may be convenient for clinical specimens. The current study was limited to cell line specimens. Further studies of molecular testing using residual clinical LBC specimens clearly are warranted to confirm the effective use of LBC specimens in the future. Moreover, the current study was limited by the fact that we investigated the effectiveness and suitability of the fixatives in stabilizing nucleic acids and allowing for molecular testing after short-term preservation. However, in the case of clinical specimens, cells often are preserved for weeks to months. Therefore, further investigation into the effectiveness of this method in long-term preservation based on practical use is needed, and we currently are working on improvements that will allow for such a study.
LBC specimens that are fixed in CytoRich Red for several days at room temperature can be used effectively and practically for routine clinical diagnosis. When using LBC for targeted molecular testing, the appropriate extraction protocol and storage conditions should be taken into consideration.
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